These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21046356)

  • 1. Beta cell function during rapamycin monotherapy in long-term type 1 diabetes.
    Piemonti L; Maffi P; Monti L; Lampasona V; Perseghin G; Magistretti P; Secchi A; Bonifacio E
    Diabetologia; 2011 Feb; 54(2):433-9. PubMed ID: 21046356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation.
    Benedini S; Ermetici F; Briganti S; Codella R; Terruzzi I; Maffi P; Caldara R; Secchi A; Nano R; Piemonti L; Alejandro R; Ricordi C; Luzi L
    Acta Diabetol; 2018 Jul; 55(7):715-722. PubMed ID: 29654388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial.
    Bolla AM; Gandolfi A; Borgonovo E; Laurenzi A; Caretto A; Molinari C; Catalano RS; Bianconi E; Monti P; Sordi V; Pellegrini S; Lampasona V; Costa S; Scavini M; Bosi E; Piemonti L
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e507-e519. PubMed ID: 33124663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.
    Liu EH; Digon BJ; Hirshberg B; Chang R; Wood BJ; Neeman Z; Kam A; Wesley RA; Polly SM; Hofmann RM; Rother KI; Harlan DM
    Diabetologia; 2009 Jul; 52(7):1369-80. PubMed ID: 19418039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
    Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes.
    Sims EK; Bahnson HT; Nyalwidhe J; Haataja L; Davis AK; Speake C; DiMeglio LA; Blum J; Morris MA; Mirmira RG; Nadler J; Mastracci TL; Marcovina S; Qian WJ; Yi L; Swensen AC; Yip-Schneider M; Schmidt CM; Considine RV; Arvan P; Greenbaum CJ; Evans-Molina C;
    Diabetes Care; 2019 Feb; 42(2):258-264. PubMed ID: 30530850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis.
    Leete P; Oram RA; McDonald TJ; Shields BM; Ziller C; ; Hattersley AT; Richardson SJ; Morgan NG
    Diabetologia; 2020 Jun; 63(6):1258-1267. PubMed ID: 32172310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
    Orban T; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Gottlieb PA; Greenbaum CJ; Marks JB; Monzavi R; Moran A; Raskin P; Rodriguez H; Russell WE; Schatz D; Wherrett D; Wilson DM; Krischer JP; Skyler JS;
    Lancet; 2011 Jul; 378(9789):412-9. PubMed ID: 21719096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk.
    Stumpp C; Beyerlein A; Ziegler AG; Bonifacio E
    Pediatr Diabetes; 2014 Nov; 15(7):528-33. PubMed ID: 24552441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.
    Keenan HA; Sun JK; Levine J; Doria A; Aiello LP; Eisenbarth G; Bonner-Weir S; King GL
    Diabetes; 2010 Nov; 59(11):2846-53. PubMed ID: 20699420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.
    Soleimanpour SA; Hirshberg B; Bunnell DJ; Sumner AE; Ader M; Remaley AT; Rother KI; Rickels MR; Harlan DM
    Cell Transplant; 2012; 21(6):1297-304. PubMed ID: 22080915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation.
    Zelle DM; Corpeleijn E; Deinum J; Stolk RP; Gans RO; Navis G; Bakker SJ
    Diabetes Care; 2013 Jul; 36(7):1926-32. PubMed ID: 23378624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes.
    Bachar-Wikstrom E; Wikstrom JD; Ariav Y; Tirosh B; Kaiser N; Cerasi E; Leibowitz G
    Diabetes; 2013 Apr; 62(4):1227-37. PubMed ID: 23274896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial.
    Ramos JS; Dalleck LC; Borrani F; Mallard AR; Clark B; Keating SE; Fassett RG; Coombes JS
    Diabetologia; 2016 Nov; 59(11):2308-2320. PubMed ID: 27480182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.
    Mirmira RG; Sims EK; Syed F; Evans-Molina C
    Curr Diab Rep; 2016 Oct; 16(10):95. PubMed ID: 27541297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES.
    Steenkamp DW; Cacicedo JM; Sahin-Efe A; Sullivan C; Sternthal E
    Endocr Pract; 2017 Dec; 23(12):1387-1393. PubMed ID: 29144809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.
    Rickels MR; Liu C; Shlansky-Goldberg RD; Soleimanpour SA; Vivek K; Kamoun M; Min Z; Markmann E; Palangian M; Dalton-Bakes C; Fuller C; Chiou AJ; Barker CF; Luning Prak ET; Naji A
    Diabetes; 2013 Aug; 62(8):2890-7. PubMed ID: 23630300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.